Rchr
J-GLOBAL ID:201901001250845016   Update date: Jul. 31, 2024

Hideki Yoshida

ヨシダ ヒデキ | Hideki Yoshida
Affiliation and department:
Job title: 助教
Research field  (5): Fetal medicine/Pediatrics ,  Tumor diagnostics and therapeutics ,  Tumor biology ,  Tumor biology ,  Tumor diagnostics and therapeutics
Research keywords  (5): 細胞療法 ,  Virotherapy ,  Oncology ,  Hematology ,  Pediatrics
Research theme for competitive and other funds  (19):
  • 2023 - 2026 Development of gene cell therapy using mesenchymal stromal cells for neuroblastoma
  • 2023 - 2026 Development of novel gene therapy for rhabdomyosarcoma
  • 2023 - 2026 WT1プロモーター制御性ウイルスによる小児悪性固形腫瘍に対する新たな治療戦略
  • 2022 - 2025 Characterization of PLAGL1-FOXO1 fusion gene in alveolar rhabdomyosarcoma
  • 2021 - 2024 Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
Show all
Papers (53):
  • 村田 直哉, 松川 幸弘, 沢田 有里, 池田 勇八, 坂本 謙一, 南川 洋平, 富田 晃正, 吉田 秀樹, 宮地 充, 大曽根 眞也, et al. 脊髄圧迫によるOncologic Emergencyをきたした胸椎原発ランゲルハンス細胞組織球症の1例. 日本小児科学会雑誌. 2024. 128. 2. 348-348
  • Mitsuru Miyachi, Yohei Sugimoto, Yuya Sugitatsu, Akimasa Tomida, Hideki Yoshida, Kunihiko Tsuchiya, Daisuke Umebayashi, Takumi Yamanaka, Naoya Hashimoto, Yukiko Shishido-Hara, et al. Entrectinib treatment induces a durable response against <i>ARHGEF11::NTRK1</i> fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma. Pediatric Blood & Cancer. 2023
  • Kenji Okamoto, Toshihiko Imamura, Seiji Tanaka, Takayo Urata, Hideki Yoshida, Norio Shiba, Tomoko Iehara. The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells. International Journal of Hematology. 2023
  • Azusa Mayumi, Toshihiko Imamura, Hideki Yoshida, Shinya Osone, Takahiko Yasuda, Tomoko Iehara. Leukaemic cells expressing ETV6::FRK are sensitive to dasatinib in vivo. eJHaem. 2023
  • Chika Shoji, Ken Kikuchi, Hideki Yoshida, Mitsuru Miyachi, Shigeki Yagyu, Kunihiko Tsuchiya, Takaaki Nakaya, Hajime Hosoi, Tomoko Iehara. In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma. Oncology reports. 2023. 49. 4
more...
MISC (18):
more...
Lectures and oral presentations  (20):
  • A case of pediatric TAFRO syndrome successfully treated with chemotherapy
    (2023)
  • 当院における小児がん症例の妊孕性温存療法の現状と課題
    (第36回近畿小児科学会 2023)
  • A case of myeloproliferative neoplasm with both ALK-fusion gene and monosomy 7
    (2021)
  • MYOG promoter-controlled oncolytic adenovirus with MEF2 mutation kills PAX3-FOXO1 positive rhabdomyosarcoma cells selectively
    (61st Annual Meeting of the Japanese Society of Pediatric Hematology / Oncology 2019)
  • AdMG-MYOGp-E1-5/3F, MYOG promoter controlled oncolytic adenovirus, kills rhabdomyosarcoma cells selectively in vivo
    (51st Congress of the International Society of Paediatric Oncology 2019)
more...
Education (2):
  • 2012 - 2016 Kyoto Prefectural University of Medicine Graduated school of Medical Science Department of Pediatrics
  • 1998 - 2004 Kyoto Prefectural University of Medicine The Medical Faculty Department of Medicine
Professional career (2):
  • MD (Kyoto prefectural university of medicine)
  • PhD (Kyoto prefectural university of medicine)
Work history (8):
  • 2020/04 - 現在 Kyoto Prefectural University of Medicine Department of Pediatrics Assistant Professor
  • 2019/04 - 2020/03 Kyoto Prefectural University of Medicine Professional Training Center in Cancer Medicine Assistant Professor
  • 2016/04 - 2019/03 University of Minnesota Division of Basic and Translational Research, Department of Surgery Postdoctoral associate
  • 2012/04 - 2016/03 North Medical Center, Kyoto Prefectural University of Medicine Department of Pediatrics Assistant head physician
  • 2008/04 - 2012/03 Kyoto Prefectural University of Medicine Department of Pediatrics, Graduated school of Medical Science Graduated student
Show all
Awards (7):
  • 2022/11 - 公益信託日本白血病研究基金 日本白血病研究基金 小児領域特別研究賞「毎日賞」 複数回の造血幹細胞移植を実施した小児急性骨髄性白血 病難治例を対象とした、1治療成績と予後因子の検討 2緩和ケアの評価および体制整備の充実に向けた検討
  • 2022/10 - 公益財団法人がんの子どもを守る会 治療研究助成金 小児急性骨髄性白血病(AML)および骨髄増殖性疾患(MPN)におけるALK/ROS1融合遺伝子の臨床的意義の検討
  • 2021/11 - ENT M Dr.浅野登&暉子基金 「ENT M Dr.浅野登&暉子基金」医学基礎研究助成奨励金 ラブドイド腫瘍に対する新規ウイルス療法の開発
  • 2019/05 - American Society of Gene & Cell Therapy Travel Award, 22st Annual Meeting of ASGCT AdMG-MYOGp(S)-E1-5/3F, MYOG promoter-controlled oncolytic adenovirus, selectively kills rhabdomyosarcoma cells
  • 2014/11 - Japanese Society of Pediatric Hematology / Oncology Best Poster Award, 56th Congress of JPHO Analysis of the risk factors for hyperglycemia related to L-asparaginase in the patients with ALL registered
Show all
Association Membership(s) (7):
日本遺伝子細胞治療学会 ,  Japan Society of Clinical Oncology ,  THE JAPANESE CANCER ASSOCIATION ,  Jpanese Society for Transplantation and Cellular Therapy ,  THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  JAPAN PEDIATRIC SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page